Sarepta Therapeutics Inc (SRPT)

Fixed asset turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	1,243,340	933,013	701,887	540,099	380,833
Property, plant and equipment	US$ in thousands	227,154	180,037	191,156	190,430	129,620
Fixed asset turnover		5.47	5.18	3.67	2.84	2.94

December 31, 2023 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $1,243,340K ÷ $227,154K
= 5.47

Fixed asset turnover measures how efficiently a company generates revenue from its investments in fixed assets. Sarepta Therapeutics Inc's fixed asset turnover has shown a positive trend over the past five years, increasing from 2.94 in 2019 to 5.47 in 2023. This indicates that the company has been able to generate more revenue relative to its investment in fixed assets.

The significant improvement in fixed asset turnover suggests that Sarepta Therapeutics has been utilizing its fixed assets more efficiently in recent years. This could be a result of better asset management practices, operational improvements, or an increase in revenue generation. A higher fixed asset turnover ratio is generally considered favorable, as it implies that the company is maximizing the use of its assets to generate sales.

Overall, the steady increase in Sarepta Therapeutics Inc's fixed asset turnover ratio reflects positively on the company's operational efficiency and ability to generate revenue from its investment in fixed assets.